FIELD: medicine, endocrinology, ophthalmology. SUBSTANCE: method involves the prescription to patient eiconol orally at the dose 2.0-4.0 g, twice per 24 h for 12-20 days before reinfusion of UV-irradiated own blood. EFFECT: enhanced effectiveness of treatment by UV-irradiation. 1 tbl, 2 ex
Title | Year | Author | Number |
---|---|---|---|
METHOD OF TREATMENT OF PATIENTS WITH DIABETIC RETINOPATHY | 1996 |
|
RU2124337C1 |
METHOD OF PROPHYLAXIS OF DIABETIC RETINOPATHY | 1996 |
|
RU2140235C1 |
METHOD FOR TREATING VASCULAR DISEASES OF EYES | 1995 |
|
RU2123870C1 |
METHOD FOR TREATING PRE- AND PROLIFERATIVE DIABETIC RHETINOPATHY | 1996 |
|
RU2123829C1 |
METHOD FOR TREATING DIABETIC RETINOPATHY | 2004 |
|
RU2270025C1 |
METHOD FOR TREATING THE CASES OF GLAUCOMA | 1996 |
|
RU2135131C1 |
METHOD FOR DIAGNOSING THE CASES OF GLAUCOMA | 1996 |
|
RU2135087C1 |
METHOD FOR TREATING OEDEMATOUS FORM OF DIABETIC MACULORETINOPAHTY | 2008 |
|
RU2367386C1 |
METHOD FOR TREATMENT OF PATIENTS WITH DIABETES MELLITUS | 2004 |
|
RU2270017C1 |
METHOD FOR TREATING DIABETIC RETINOPATHY | 1999 |
|
RU2157154C1 |
Authors
Dates
1999-10-27—Published
1996-08-20—Filed